Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ.

Eur Heart J. 2010 Sep;31(17):2111-23. doi: 10.1093/eurheartj/ehq136. Epub 2010 May 31.

2.

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.

Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ.

Circulation. 2006 Jul 18;114(3):216-25. Epub 2006 Jul 10.

3.

Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.

Hamada T, Kubo T, Kitaoka H, Hirota T, Hoshikawa E, Hayato K, Shimizu Y, Okawa M, Yamasaki N, Matsumura Y, Yabe T, Takata J, Doi YL.

Clin Cardiol. 2010 Jul;33(7):E24-8. doi: 10.1002/clc.20533.

4.

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.

J Cardiovasc Magn Reson. 2009 Sep 9;11:34. doi: 10.1186/1532-429X-11-34.

7.

Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.

Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS.

Circ Heart Fail. 2014 Nov;7(6):967-75. doi: 10.1161/CIRCHEARTFAILURE.114.001435. Epub 2014 Sep 19.

8.

Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.

Hecht GM, Klues HG, Roberts WC, Maron BJ.

J Am Coll Cardiol. 1993 Aug;22(2):489-97.

9.

Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.

Małek LA, Chojnowska L, Kłopotowski M, Misko J, Dabrowski M, Kuśmierczyk-Droszcz B, Maczyńska R, Piotrowicz E, Ruzyłło W.

Kardiol Pol. 2009 Jan;67(1):1-6; discussion 7-8.

10.

Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ.

N Engl J Med. 2003 Jan 23;348(4):295-303.

11.

Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations.

Coppini R, Ho CY, Ashley E, Day S, Ferrantini C, Girolami F, Tomberli B, Bardi S, Torricelli F, Cecchi F, Mugelli A, Poggesi C, Tardiff J, Olivotto I.

J Am Coll Cardiol. 2014 Dec 23;64(24):2589-600. doi: 10.1016/j.jacc.2014.09.059.

12.

Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG.

J Am Coll Cardiol. 2006 Mar 7;47(5):1043-8.

13.

Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.

Kubo T, Kitaoka H, Okawa M, Yamanaka S, Hirota T, Hoshikawa E, Hayato K, Yamasaki N, Matsumura Y, Yasuda N, Sugiura T, Doi YL.

Clin Cardiol. 2010 Feb;33(2):E1-7. doi: 10.1002/clc.20622.

14.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE.

JAMA. 2009 Mar 25;301(12):1253-9. doi: 10.1001/jama.2009.371.

15.

Natural history of hypertrophic cardiomyopathy: Japanese experience.

Koga Y, Miyamoto T, Ohtsuki T, Toshima H.

J Cardiol. 2001;37 Suppl 1:147-54.

PMID:
11433819
16.

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ.

Circulation. 2006 Nov 21;114(21):2232-9. Epub 2006 Nov 6.

17.

["Severe" congestive heart failure at a medical center].

Ferreira P, Fonseca C, Morais H, Carvalho A, Ceia F, Luís AS.

Rev Port Cardiol. 1993 Nov;12(11):919-30, 900. Portuguese.

PMID:
8305244
18.

Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ.

Circulation. 2001 Nov 20;104(21):2517-24.

19.

Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F.

Circulation. 2000 Aug 22;102(8):858-64.

20.

[Association between diastolic dysfunction evaluated by left ventricular flow propagation velocity and outcome in patients with hypertrophic cardiomyopathy].

Wu D, Xue J, Zhou YQ, Zhang WJ, Qu Z, Hu DY.

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Nov;38(11):983-8. Chinese.

PMID:
21215226
Items per page

Supplemental Content

Write to the Help Desk